sexual_healthMedium Risk

Triptorelin

Also known as: Decapeptyl, Trelstar, GnRH agonist

Half-life:: ~7-8 hours (single dose) / ~5-7 weeks (depot form)

Administration Routes

subcutaneous injectionintramuscular injection

PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

Potent GnRH agonist; single pulse stimulates LH/FSH surge and restores HPG axis after suppression (e.g., post-steroid cycle)

A potent GnRH agonist used for HPTA restart after hormonal suppression. Single dose can restore natural testosterone production in post-cycle therapy.

Primary Research Areas

HPG axis restart
testosterone restoration
HPTA recovery

Risk Profile

Medium Risk

Moderate risk profile in research contexts. Consult a healthcare professional before use.

Regulatory Status

Prescription OnlyFDA Approved

FDA-approved GnRH agonist. Brand: Trelstar (NDA 020726, Jun 2000). Indicated for advanced prostate cancer. Also used off-label for precocious puberty and chemical castration. Prescription only.

Effective: June 15, 2000View FDA source →

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Where to Find Triptorelin

No active associated providers listed yet.